Orphazyme A/S ADR (ORPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ORPH | BMY | AMGN | GILD | VRTX |
| Company | Orphazyme A/S ADR | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.9060 | 49.89 | 337.03 | 84.39 | 477.70 |
| High | 0.9571 | 50.04 | 338.70 | 84.65 | 482.21 |
| Low | 0.8457 | 49.11 | 334.61 | 83.57 | 476.27 |
| Last | 0.8700 | 49.44 | 337.27 | 84.49 | 482.25 |
| Change | -0.0200 | -0.30 | +4.35 | +0.60 | +8.09 |
| % Change | -2.25% | -0.60% | +1.31% | +0.72% | +1.71% |
| Volume | 941,400 | 3,074,769 | 613,278 | 3,507,688 | 369,033 |
| 20-Day Average Volume | 1,980,090 | 8,313,873 | 1,708,644 | 6,418,723 | 957,592 |
| Previous Close | 0.8900 | 49.74 | 332.92 | 83.89 | 474.16 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.9128 | 49.11 | 329.63 | 80.10 | 480.06 |
| 20-Day Raw Stochastic | 41.76% | 63.63% | 89.40% | 95.28% | 53.35% |
| 20-Day Relative Strength | 36.52% | 55.66% | 58.35% | 72.89% | 51.33% |
| Weighted Alpha | -87.89 | -10.39 | +27.58 | +19.29 | +35.05 |
| Today's Opinion | 100% Sell | 72% Buy | 96% Buy | 88% Buy | 56% Buy |
| Previous Opinion | 100% Sell | 72% Buy | 88% Buy | 88% Buy | 40% Buy |
| Last Month's Opinion | 100% Sell | 40% Buy | 88% Buy | 56% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.47% since 03/23/22 | +2.29% since 09/12/24 | +2.07% since 09/12/24 | +1.54% since 09/12/24 | +0.66% since 09/12/24 |
| Low | 0.8275 on 03/29/22 | 48.20 on 09/13/24 | 327.15 on 09/13/24 | 81.57 on 09/13/24 | 473.75 on 09/18/24 |
| High | 0.9600 on 03/29/22 | 50.41 on 09/17/24 | 339.00 on 09/18/24 | 84.61 on 09/19/24 | 490.15 on 09/16/24 |
| 1-Month | |||||
| %Chg | -28.69% since 02/28/22 | +0.09% since 08/19/24 | +2.72% since 08/19/24 | +13.42% since 08/19/24 | -1.28% since 08/19/24 |
| Low | 0.5101 on 03/14/22 | 46.88 on 08/22/24 | 319.00 on 09/06/24 | 74.34 on 08/20/24 | 460.69 on 09/11/24 |
| High | 1.3720 on 03/10/22 | 50.75 on 09/04/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 500.25 on 08/30/24 |
| 3-Month | |||||
| %Chg | -67.29% since 12/28/21 | +20.91% since 06/18/24 | +10.10% since 06/18/24 | +33.71% since 06/18/24 | +3.11% since 06/18/24 |
| Low | 0.5101 on 03/14/22 | 39.35 on 07/05/24 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 458.04 on 08/13/24 |
| High | 2.7500 on 01/03/22 | 51.19 on 07/29/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 |
| 6-Month | |||||
| %Chg | -79.33% since 09/28/21 | -4.74% since 03/19/24 | +23.98% since 03/19/24 | +15.03% since 03/19/24 | +16.04% since 03/19/24 |
| Low | 0.5101 on 03/14/22 | 39.35 on 07/05/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 391.01 on 04/18/24 |
| High | 5.4900 on 10/13/21 | 54.47 on 03/28/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 30,721 | 100,827,960 | 178,589,936 | 104,514,608 | 122,358,416 |
| Shares Outstanding, K | 35,312 | 2,027,100 | 536,435 | 1,245,853 | 258,053 |
| Annual Sales | 0 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -97,010,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | N/A | 12,201,000,000 | 8,388,000,000 | 6,954,000,000 | 2,645,600,000 |
| Last Quarter Net Income | N/A | 1,680,000,000 | 746,000,000 | 1,614,000,000 | -3,593,600,000 |
| 60-Month Beta | 1.68 | 0.46 | 0.61 | 0.18 | 0.40 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.07 on 07/26/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | -12.83 on 08/01/24 |
| Latest Earnings Date | 04/05/22 | 10/31/24 | 10/29/24 | 11/05/24 | 11/04/24 |
| Most Recent Dividend | N/A | 0.600 on 07/05/24 | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 10/04/24 | 08/16/24 | 09/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 36.12 | 17.89 | 17.67 | 0.00 |